Advertisement

Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma

Matthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom, Joseph D. Khoury, Preetesh Jain, Wendy Y. Chen, Onyeka N. Oriabure, Maria R. Badillo, L. Michael Wang and Bouthaina S. Dabaja

Article Information

Citation 
vol. 3 no. 13 2035-2039
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted January 2, 2019
  • Accepted April 30, 2019
  • Published online July 9, 2019.


Contributors 
  • Matthew S. Ning, 1Department of Radiation Oncology,
  • Chelsea C. Pinnix, 1Department of Radiation Oncology,
  • Bhavana V. Chapman, 1Department of Radiation Oncology,
  • Jillian R. Gunther, 1Department of Radiation Oncology,
  • Sarah A. Milgrom, 1Department of Radiation Oncology,
  • Joseph D. Khoury, 2Department of Hematopathology, and
  • Preetesh Jain, 3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Wendy Y. Chen, 3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Onyeka N. Oriabure, 3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Maria R. Badillo, 3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
  • L. Michael Wang, 3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
  • Bouthaina S. Dabaja, 1Department of Radiation Oncology,

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output